Magnesium Sulphate Toxicity — What Every NMCN Candidate Must Know

Magnesium sulphate toxicity has appeared across multiple NMCN professional examination sittings in 2025 and 2026. It appeared in the March 2025 Midwifery paper, the November 2025 General Nursing paper, and the 2026 sittings conducted so far. If you are preparing for the NMCN licensing examination — whether for General Nursing or Midwifery — this is one pharmacology topic you cannot afford to skip.

This guide covers everything the NMCN exam tests on magnesium sulphate: what it is, why it is used, the signs of toxicity, the antidote, and the nursing management questions that appear on the exam.

What Is Magnesium Sulphate?

Magnesium sulphate (MgSO₄) is an inorganic salt used in clinical practice primarily as an anticonvulsant and tocolytic agent. In Nigerian nursing and midwifery practice, it is most commonly associated with:

• Pre-eclampsia and eclampsia — prevention and treatment of seizures
• Preterm labour — as a tocolytic to delay premature birth
• Foetal neuroprotection — given to mothers in preterm labour to protect the baby's brain

The NMCN exam focuses almost exclusively on its use in pre-eclampsia and eclampsia management, which is where toxicity questions arise.

Why Magnesium Sulphate Causes Toxicity

Magnesium sulphate has a narrow therapeutic window. The therapeutic serum magnesium level is 4–7 mEq/L. Once serum levels rise above this range, toxic effects begin to appear in a predictable sequence based on the degree of elevation.

Understanding this progression is essential for the NMCN exam because questions often ask you to identify which sign indicates toxicity, what the nurse should do first, or which finding should prompt the nurse to stop the infusion.

Signs of Magnesium Sulphate Toxicity — In Order of Appearance

This is the most tested section. Learn this sequence:

Early Toxicity (Serum Mg: 7–10 mEq/L)

• Flushing and feeling of warmth
• Nausea and vomiting
• Double vision (diplopia)
• Slurred speech
• Muscle weakness

Moderate Toxicity (Serum Mg: 10–13 mEq/L)

• Loss of deep tendon reflexes — this is the most important early warning sign on the NMCN exam
• Absent patellar (knee-jerk) reflex — specifically tested; a nurse checks this before each dose
• Extreme drowsiness
• Hypotension

Severe Toxicity (Serum Mg: 13–15 mEq/L)

• Respiratory depression — respiratory rate below 12 breaths per minute
• Respiratory paralysis

Fatal Toxicity (Serum Mg: >15 mEq/L)

• Cardiac arrest

The Three Signs the NMCN Exam Focuses On

The examination consistently focuses on three specific signs of magnesium sulphate toxicity. Memorise these:

1. Absent patellar reflex (knee-jerk reflex) The patellar reflex is the first deep tendon reflex to disappear as magnesium levels rise. The NMCN exam tests this repeatedly. Before each dose of magnesium sulphate, the nurse must check the patellar reflex. If it is absent, the infusion must be stopped immediately.

2. Respiratory rate below 12 breaths per minute Respiratory depression is a life-threatening sign of magnesium toxicity. The nurse must monitor respiratory rate continuously during magnesium sulphate infusion. A respiratory rate below 12 is a red flag that requires immediate action.

3. Reduced urine output (oliguria) Magnesium is excreted exclusively through the kidneys. If urine output falls below 25–30 mL per hour, magnesium accumulates in the body and toxicity risk increases significantly. Urine output monitoring is therefore a critical nursing responsibility during magnesium sulphate infusion.

The Antidote — Calcium Gluconate

This is the single most important fact on this topic for the NMCN exam:

The antidote for magnesium sulphate toxicity is calcium gluconate.

Specifically:

• Dose: 1 gram (10 mL of 10% solution) of calcium gluconate
• Route: Intravenous, given slowly over 3 minutes
• Mechanism: Calcium antagonises the neuromuscular blocking effects of excess magnesium

The NMCN exam may ask:

• What is the antidote for magnesium sulphate toxicity? → Calcium gluconate
• What should the nurse have at the bedside during magnesium sulphate infusion? → Calcium gluconate
• What does the nurse administer when a patient shows signs of magnesium toxicity? → Calcium gluconate

Calcium gluconate must always be kept at the bedside whenever magnesium sulphate is being administered. This is a standard nursing responsibility that the exam tests directly.

Nursing Management During Magnesium Sulphate Infusion

The NMCN exam does not just test knowledge of signs and antidotes — it also tests the nurse's clinical actions. Here is what you need to know:

Before Starting the Infusion

• Obtain baseline vital signs
• Check patellar reflexes
• Check urine output
• Ensure calcium gluconate is available at the bedside
• Have resuscitation equipment accessible

During the Infusion — Monitor Continuously

Check and document every hour:

If Toxicity Is Suspected

1. Stop the magnesium sulphate infusion immediately
2. Administer calcium gluconate 1g IV slowly (over 3 minutes)
3. Maintain airway — position patient, prepare for possible intubation
4. Administer oxygen
5. Monitor vital signs continuously
6. Notify the physician immediately
7. Document all findings and actions

How NMCN Questions Are Framed

Understanding the question format is as important as knowing the content. Here are the types of questions that have appeared:

Scenario 1 — Identify the sign: "A patient receiving magnesium sulphate for pre-eclampsia has a respiratory rate of 10 breaths per minute and absent knee-jerk reflex. What does the nurse do first?" → Stop the infusion and administer calcium gluconate

Scenario 2 — Identify the antidote: "Which drug should the nurse have at the bedside during magnesium sulphate administration?" → Calcium gluconate

Scenario 3 — Identify the monitoring priority: "Which finding during magnesium sulphate infusion requires the nurse to stop the infusion immediately?" → Absent patellar reflex OR respiratory rate below 12

Scenario 4 — Identify the nursing action: "A patient on magnesium sulphate infusion has urine output of 20 mL in the last hour. What is the priority nursing action?" → Stop the infusion and notify the physician

Quick Review — What to Memorise

Before your NMCN exam, make sure you can answer these instantly:

What is magnesium sulphate used for in obstetrics? Prevention and treatment of seizures in pre-eclampsia and eclampsia

What are the three key signs of toxicity? Absent patellar reflex, respiratory rate below 12, urine output below 25 mL/hour

What is the antidote? Calcium gluconate 1g IV slowly over 3 minutes

What must be at the bedside during infusion? Calcium gluconate and resuscitation equipment

What is the therapeutic serum level? 4–7 mEq/L

What is the first nursing action when toxicity is suspected? Stop the infusion immediately

Practice This Topic on PassMate

PassMate has over 11,000 real NMCN past questions including pharmacology questions on magnesium sulphate, drug calculations, and obstetric emergencies. The AI tutor can explain any concept in detail, walk you through clinical scenarios, and test your understanding with follow-up questions.

If you are preparing for the September 2026 NMCN sitting, start practising today:

Try PassMate free — passmate.ng/nmcn

Frequently Asked Questions

Does magnesium sulphate toxicity appear in every NMCN sitting?

Not in every sitting, but it has appeared in multiple 2025 and 2026 papers across both General Nursing and Midwifery programmes. Given its high frequency in recent sittings, it is a high-priority topic for any candidate preparing for upcoming exams.

Is calcium gluconate the same as calcium chloride?

No. Both are calcium salts and both can reverse magnesium toxicity, but calcium gluconate is preferred because it is less irritating to tissues if extravasation occurs. The NMCN exam specifically tests calcium gluconate as the antidote.

What is the difference between magnesium sulphate toxicity and hypomagnesaemia?

Toxicity is excess magnesium (serum level above 7 mEq/L), causing neuromuscular depression. Hypomagnesaemia is deficient magnesium (below 1.5 mEq/L), causing neuromuscular excitability — tremors, tetany, seizures. They are opposite conditions with opposite clinical presentations. The NMCN exam may test both.

Can a breastfeeding mother receive magnesium sulphate?

Yes. Magnesium sulphate is compatible with breastfeeding. It passes into breast milk in small amounts but is not considered harmful to the infant at therapeutic doses.